Literature DB >> 24090820

α-Iso-cubebene exerts neuroprotective effects in amyloid beta stimulated microglia activation.

Sun Young Park1, Se Jin Park, Nan Jeong Park, Woo Hong Joo, Sang-Joon Lee, Young-Whan Choi.   

Abstract

Schisandra chinensis is commonly used for food and as a traditional remedy for the treatment of neuronal disorders. However, it is unclear which component of S. chinensis is responsible for its neuropharmacological effects. To answer this question, we isolated α-iso-cubebene, a dibenzocyclooctadiene lignin, from S. chinensis and determined if it has any anti-neuroinflammatory and neuroprotective properties against amyloid β-induced neuroinflammation in microglia. Microglia that are stimulated by amyloid β increased their production of pro-inflammatory cytokines and chemokines, prostaglandin E2 (PGE2), nitric oxide (NO) and reactive oxygen species (ROS) and the enzymatic activity of matrix metalloproteinase 9 (MMP-9). We found this was all inhibited by α-iso-cubebene. Consistent with these results, α-iso-cubebene inhibited the expression of inducible nitric oxide synthase (iNOS), cyclooxygenase 2 (COX-2) and MMP-9 in amyloid β-stimulated microglia. Subsequent mechanistic studies revealed that α-iso-cubebene inhibited the phosphorylation and degradation of IκB-α, the phosphorylation and transactivity of NF-κB, and the phosphorylation of MAPK in amyloid β-stimulated microglia. These results suggest that α-iso-cubebene impairs the amyloid β-induced neuroinflammatory response of microglia by inhibiting the NF-κB and MAPK signaling pathways. Importantly, α-iso-cubebene can provide critical neuroprotection for primary cortical neurons against amyloid β-stimulated microglia-mediated neurotoxicity. To the best of our knowledge, this is the first report showing that α-iso-cubebene can provide neuroprotection against, and influence neuroinflammation triggered by, amyloid β activation of microglia.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Amyloid β; Microglia; NF-κB; Neuroinflammation; ROS; α-Iso-cubebene

Mesh:

Substances:

Year:  2013        PMID: 24090820     DOI: 10.1016/j.neulet.2013.09.053

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  The neuroprotective effects of α-iso-cubebene on dopaminergic cell death: involvement of CREB/Nrf2 signaling.

Authors:  Sun Young Park; Beung Gu Son; Young Hoon Park; Cheol-Min Kim; Geuntae Park; Young-Whan Choi
Journal:  Neurochem Res       Date:  2014-07-01       Impact factor: 3.996

Review 2.  Mini review-vanadium-induced neurotoxicity and possible targets.

Authors:  Madhuri Ramji Jaiswal; Pravin Popatrao Kale
Journal:  Neurol Sci       Date:  2019-12-14       Impact factor: 3.307

3.  Characterization of lignin-degrading enzymes (LDEs) from a dimorphic novel fungus and identification of products of enzymatic breakdown of lignin.

Authors:  Lipin Dev Mundur Sahadevan; Chandra Shekhar Misra; V Thankamani
Journal:  3 Biotech       Date:  2016-02-13       Impact factor: 2.406

Review 4.  Recent Advances in the Inhibition of p38 MAPK as a Potential Strategy for the Treatment of Alzheimer's Disease.

Authors:  Jong Kil Lee; Nam-Jung Kim
Journal:  Molecules       Date:  2017-08-02       Impact factor: 4.411

Review 5.  Schisandra chinensis Fructus and Its Active Ingredients as Promising Resources for the Treatment of Neurological Diseases.

Authors:  Minyu Zhang; Liping Xu; Hongjun Yang
Journal:  Int J Mol Sci       Date:  2018-07-06       Impact factor: 5.923

6.  Revealing the Pharmacological Mechanism of Acorus tatarinowii in the Treatment of Ischemic Stroke Based on Network Pharmacology.

Authors:  FengZhi Liu; Qian Zhao; Suxian Liu; Yingzhi Xu; Dongrui Zhou; Ying Gao; Lingqun Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-31       Impact factor: 2.629

7.  α-Isocubebene modulates vascular tone by inhibiting myosin light chain phosphorylation in murine thoracic aorta.

Authors:  Byeong Hyeok Ye; Eun Jung Kim; Seung Eun Baek; Young Whan Choi; So Youn Park; Chi Dae Kim
Journal:  Korean J Physiol Pharmacol       Date:  2018-06-25       Impact factor: 2.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.